Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
O-I Glass | OI | Apr 26, 2024 | 15.07 | +1.48 |
Oak Valley Bancorp | OVLY | Apr 26, 2024 | 24.34 | +1.12 |
Oak Woods Acquisition | OAKU | Apr 26, 2024 | 10.77 | +0.09 |
Oaktree Capital A Pref | OAK-A | Apr 26, 2024 | 21.75 | +0.28 |
Oaktree Capital Group B Pref | OAK-B | Apr 26, 2024 | 21.50 | 0.00 |
Oaktree Specialty | OCSL | Apr 26, 2024 | 19.83 | +0.81 |
Oatly ADR | OTLY | Apr 26, 2024 | 1.00 | +14.37 |
Oblong | OBLG | Apr 26, 2024 | 0.11 | -2.56 |
OCA Acquisition A | OCAX | Apr 26, 2024 | 10.93 | -0.09 |
Occidental Petroleum | OXY | Apr 26, 2024 | 67.78 | -0.15 |
Ocean Biomedical | OCEA | Apr 26, 2024 | 1.34 | +6.77 |
Ocean Power Technologies | OPTT | Apr 26, 2024 | 0.19 | +0.80 |
Oceaneering International | OII | Apr 26, 2024 | 24.90 | +1.43 |
OceanFirst Financial | OCFC | Apr 26, 2024 | 15.37 | +0.92 |
OceanFirst Pref | OCFCP | Apr 26, 2024 | 24.54 | -0.65 |
OceanPal | OP | Apr 26, 2024 | 2.42 | +2.98 |
Ocugen | OCGN | Apr 26, 2024 | 1.28 | +8.47 |
Ocular Therapeutix | OCUL | Apr 26, 2024 | 4.75 | +12.98 |
Oculis | OCS | Apr 26, 2024 | 12.02 | +0.59 |
Ocuphire Pharma | OCUP | Apr 26, 2024 | 1.61 | +4.89 |
Ocwen Financial | OCN | Apr 26, 2024 | 24.33 | +0.41 |
Oddity Tech | ODD | Apr 26, 2024 | 32.19 | +1.48 |
Odyssey Marine Exploration | OMEX | Apr 26, 2024 | 3.53 | -3.02 |
Offerpad Solutions A | OPAD | Apr 26, 2024 | 8.29 | +2.09 |
Office Properties | OPI | Apr 26, 2024 | 2.01 | +3.61 |
OFG Bancorp | OFG | Apr 26, 2024 | 36.30 | -0.44 |
OFS Capital | OFS | Apr 26, 2024 | 9.46 | -2.73 |
OFS Credit | OCCI | Apr 26, 2024 | 7.04 | +0.64 |
OFS Credit C Pref | OCCIO | Apr 26, 2024 | 24.09 | +1.43 |
OFS Credit E Pref | OCCIN | Apr 26, 2024 | 22.89 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.